The long term goal of our research is to design complex biomaterial scaffolds that can mimic the micro- architecture of cardiac tissues and to augment regeneration therapies. These tissue-like structures will have the appropriate microarchitectural features of native tissues including a functioning vasculature. To fabricate these tissues we are interested in using natural molecules such as hyaluronic acid (HA;also called hyaluronan)-based biomaterials, because of the ubiquitous presence of HA in the extracellular matrix (ECM) of tissues and the significant role that HA inherently plays in wound healing. The objective of the proposed research is to develop methods to create 3D scaffolds of native ECM components with complex internal architecture and cell encapsulation. To fabricate such scaffolds, we will develop an innovative direct-write platform based on a projection-style stereolithographic (SL) method, coined as PSL.
In Specific Aim 1, we will develop and optimize the PSL system for the fabrication of 3D microstructures using HA with Arg-Gly-Asp (RGD) and matrix metalloproteinase (MMP).
In Specific Aim 2, we will use PSL for Direct-write 3D HA scaffolds encapsulating cardiomyocytes.
In Specific Aim 3, we will create vascularized structures in a 3D scaffold and analyze vasculature functions. We will seed an endothelial cell lining within microchannels. The seeding process will be optimized by adjusting the cell seeding density and duration as well as surface chemistry. The vascular function and biomechanical properties of these engineered tissue constructs will be determined in vitro.

Public Health Relevance

This project seeks to develop a novel biofabrication platform to create three-dimensional (3D) scaffolds of native extracellular matrix components with complex internal architectures and cell encapsulation. The goal of the project is to create vascularized structures in the 3D scaffolds

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB012597-03
Application #
8311558
Study Section
Instrumentation and Systems Development Study Section (ISD)
Program Officer
Hunziker, Rosemarie
Project Start
2010-09-30
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
3
Fiscal Year
2012
Total Cost
$360,540
Indirect Cost
$59,474
Name
University of California San Diego
Department
Engineering (All Types)
Type
Schools of Arts and Sciences
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Saghazadeh, Saghi; Rinoldi, Chiara; Schot, Maik et al. (2018) Drug delivery systems and materials for wound healing applications. Adv Drug Deliv Rev 127:138-166
Shin, Su Ryon; Migliori, Bianca; Miccoli, Beatrice et al. (2018) Electrically Driven Microengineered Bioinspired Soft Robots. Adv Mater 30:
Yang, Jingzhou; Zhang, Yu Shrike; Yue, Kan et al. (2017) Cell-laden hydrogels for osteochondral and cartilage tissue engineering. Acta Biomater 57:1-25
Shin, Su Ryon; Kilic, Tugba; Zhang, Yu Shrike et al. (2017) Label-Free and Regenerative Electrochemical Microfluidic Biosensors for Continual Monitoring of Cell Secretomes. Adv Sci (Weinh) 4:1600522
Zhao, Xin; Sun, Xiaoming; Yildirimer, Lara et al. (2017) Cell infiltrative hydrogel fibrous scaffolds for accelerated wound healing. Acta Biomater 49:66-77
Cha, Byung-Hyun; Shin, Su Ryon; Leijten, Jeroen et al. (2017) Integrin-Mediated Interactions Control Macrophage Polarization in 3D Hydrogels. Adv Healthc Mater 6:
Massa, Solange; Sakr, Mahmoud Ahmed; Seo, Jungmok et al. (2017) Bioprinted 3D vascularized tissue model for drug toxicity analysis. Biomicrofluidics 11:044109
Zhang, Yu Shrike; Yue, Kan; Aleman, Julio et al. (2017) 3D Bioprinting for Tissue and Organ Fabrication. Ann Biomed Eng 45:148-163
Leijten, Jeroen; Seo, Jungmok; Yue, Kan et al. (2017) Spatially and Temporally Controlled Hydrogels for Tissue Engineering. Mater Sci Eng R Rep 119:1-35
González-González, Everardo; Alvarez, Mario Moisés; Márquez-Ipiña, Alan Roberto et al. (2017) Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead. Crit Rev Biotechnol 37:53-68

Showing the most recent 10 out of 128 publications